Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease

Roya Kelishadi1, Parinaz Poursafa

  • 1Pediatrics Department, Child Health Promotion Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran.

Hepatitis Monthly
|January 7, 2012
PubMed

Insights

Pediatric non-alcoholic fatty liver disease (NAFLD) is rising due to obesity and environmental factors like air pollution. Understanding NAFLD

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Environmental Health
  • Metabolic Disorders

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a significant and growing health concern in children.
  • While obesity is a primary driver, environmental factors including smoking and air pollution are increasingly implicated in pediatric NAFLD.
  • Systemic inflammation, oxidative stress, and insulin resistance are key etiological factors linking obesity and environmental exposures to NAFLD.

Purpose of the Study:

  • To review the current epidemiological data on pediatric NAFLD.
  • To discuss the diagnostic approaches for NAFLD in children.
  • To explore the underlying pathogenetic mechanisms of pediatric NAFLD and emphasize prevention strategies.

Main Methods:

  • Comprehensive literature review of existing studies on pediatric NAFLD.
  • Analysis of epidemiological trends, diagnostic criteria, and etiological factors.
  • Synthesis of current knowledge on pathogenesis, focusing on obesity and environmental influences.

Main Results:

  • Pediatric NAFLD incidence is escalating, driven by obesity and environmental exposures.
  • Key etiological factors include inflammation, oxidative stress, and insulin resistance.
  • The review consolidates current understanding of NAFLD epidemiology, diagnosis, and pathogenesis in children.

Conclusions:

  • Further research into the mechanisms of pediatric NAFLD is crucial.
  • Broadening prevention and control efforts for obesity and air pollution is essential.
  • Addressing these risk factors can mitigate the serious health consequences of pediatric NAFLD.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...